Mergers and Acquisitions

Novartis’ AveXis to Acquire Manufacturing Site for Gene Therapies

April 02, 2019

Adding to an existing $115-million investment, the 700,000-ft2 site in Longmont, CO will expand AveXis’ gene-therapy manufacturing capacity.

Fujifilm to Acquire Large-Scale Biologics Manufacturing Site from Biogen in $890-Million Deal

March 12, 2019

The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.

Biogen to Acquire Gene-Therapy Company Nightstar in $800-Million Deal

March 05, 2019

The acquisition will establish a clinical pipeline for Biogen of gene-therapy candidates in ophthalmology.

GHO Capital Acquires Sterling Pharma Solutions

March 01, 2019

GHO Capital, a European specialist investor in healthcare, announced its acquisition of Sterling Pharma Solutions, which specializes in complex and difficult-to-manufacture APIs.

Roche to Acquire Spark Therapeutics

February 27, 2019

The $4.3-billion acquisition is expected to strengthen Roche’s gene therapy pipeline.

Bharat Acquires GSK’s Chiron Behring Vaccines

February 21, 2019

India’s Bharat Biotech is set to acquire GlaxoSmithKline’s Chiron Behring Vaccines, a World Health Organization-prequalified global manufacturer of rabies vaccines.

Charles River to Acquire Citoxlab in $510-Million Deal

February 19, 2019

Pharmaceutical Technology's In the Lab eNewsletter

The acquisition would strengthen Charles River’s contract research capabilities.